Evotec SE (EVO) Other Accumulated Expenses (2009 - 2026)
Evotec SE (EVO) reported Other Accumulated Expenses of $29067.3 for Q1 2026, down 0.53% on a YoY basis from $29222.4 in Q1 2025, and up 16.68% sequentially from $24911.7 in Q4 2025.
Evotec SE (EVO) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 9 years of Other Accumulated Expenses data on file, last reported at $29067.3 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses fell 0.53% year-over-year to $29067.3; the trailing twelve-month figure through Mar 2026 stood at $29067.3 (down 0.53% YoY), and the FY2025 full-year result was $24911.7, down 15.06% from the prior year.
- Other Accumulated Expenses grew to $29067.3 in Q1 2026, from $24911.7 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $32666.9 in Q3 2025 to a low of $11984.3 in Q1 2022.
- A 5-year average of $25113.9 and a median of $27445.3 in 2025 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses fell 28.48% in 2022 and grew 24.45% in 2025, its largest moves.
- Tracing EVO's Other Accumulated Expenses over 5 years: stood at $14781.3 in 2022, then soared by 64.3% to $24286.1 in 2023, then climbed by 20.76% to $29328.7 in 2024, then retreated by 15.06% to $24911.7 in 2025, then climbed by 16.68% to $29067.3 in 2026.
- Business Quant data shows EVO's Other Accumulated Expenses at $29067.3 in Q1 2026, $24911.7 in Q4 2025, and $32666.9 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,067.27 |
| Dec 31, 2025 | 24,911.70 |
| Sep 30, 2025 | 32,666.91 |
| Jun 30, 2025 | 28,641.98 |
| Mar 31, 2025 | 29,222.40 |
| Dec 31, 2024 | 29,328.67 |
| Sep 30, 2024 | 26,248.54 |
| Dec 31, 2023 | 24,286.12 |
| Sep 30, 2022 | 14,781.30 |
| Mar 31, 2022 | 11,984.32 |
| Dec 31, 2021 | 14,367.13 |
| Sep 30, 2021 | 20,668.19 |
| Dec 31, 2020 | 23,897.07 |
| Sep 30, 2010 | 366.72 |
| Jun 30, 2010 | 1,500.48 |
| Mar 31, 2010 | 1,304.40 |
| Dec 31, 2009 | 1,026.33 |
| Jun 30, 2009 | 871,454.92 |
| Mar 31, 2009 | 886,643.36 |